Set Shifting in a Rodent Model of Attention-Deficit/Hyperactivity Disorder

被引:14
作者
Chess, Amy C. [2 ]
Raymond, Brittany E. [1 ]
Gardner-Morse, Ira G. [1 ]
Stefani, Mark R. [3 ]
Green, John T. [1 ]
机构
[1] Univ Vermont, Dept Psychol, Burlington, VT 05405 USA
[2] Champlain Coll, Dept Psychol, Burlington, VT USA
[3] Middlebury Coll, Dept Psychol, Middlebury, VT USA
关键词
SHR; spontaneously hypertensive rat; ADHD; set shifting; extradimensional; SPONTANEOUSLY HYPERTENSIVE-RATS; MEDIAL PREFRONTAL CORTEX; DEFICIT HYPERACTIVITY DISORDER; NIGROSTRIATAL DOPAMINE SYSTEM; NUCLEUS-ACCUMBENS CORE; LATENT INHIBITION; ENTORHINAL CORTEX; EXECUTIVE FUNCTIONS; ANIMAL-MODEL; DIFFERENTIAL INVOLVEMENT;
D O I
10.1037/a0023571
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Two experiments compared spontaneously hypertensive rats (SHRs; a rodent model of attention-deficit/hyperactivity disorder) and Wistar rats (a normoactive control strain), on the acquisition of a set-shifting strategy. In Experiment 1, SHRs and Wistar rats were equivalent in trials to criterion to learn a brightness or a texture discrimination but SHRs were faster than Wistar rats in shifting to the opposite discrimination when there was 1 or 2 days between the initial discrimination and the shift. In Experiment 2, SHRs and Wistar rats were equivalent in shifting when the shift between discriminations occurred immediately after a criterion had been met in the first discrimination. The results are discussed in terms of a failure of SHRs to store or retrieve an initial discrimination and/or latent inhibition over a delay, leading to faster acquisition of a set-shift. This failure in storage or retrieval may be the result of a hypoactive dopamine system in the prefrontal cortex and nucleus accumbens shell as well as abnormalities in entorhinal cortex in SHRs.
引用
收藏
页码:372 / 382
页数:11
相关论文
共 50 条
  • [31] Pharmacotherapy for attention-deficit/hyperactivity disorder
    Kim, Bongseog
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2019, 62 (01): : 49 - 55
  • [32] Treatment of Attention-Deficit Hyperactivity Disorder
    Kim, Young Key
    Song, Dong Ho
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2009, 52 (05): : 489 - 499
  • [33] Homer expression in the hippocampus of an animal model of attention-deficit/hyperactivity disorder
    Hong, Qin
    Wang, Yan-Ping
    Zhang, Min
    Pan, Xiao-Qin
    Guo, Mei
    Li, Fei
    Tong, Mei-Ling
    Chen, Rong-Hua
    Guo, Xi-Rong
    Chi, Xia
    MOLECULAR MEDICINE REPORTS, 2011, 4 (04) : 705 - 712
  • [34] Inattentiveness in attention-deficit/hyperactivity disorder
    Sroubek, Ariane
    Kelly, Mary
    Li, Xiaobo
    NEUROSCIENCE BULLETIN, 2013, 29 (01) : 103 - 110
  • [35] Childhood attention-deficit/hyperactivity disorder
    Verkuijl, Nienke
    Perkins, Marian
    Fazel, Mina
    BMJ-BRITISH MEDICAL JOURNAL, 2015, 350 : h2168
  • [36] Attention-deficit/hyperactivity disorder
    Petermann, Franz
    Hampel, Petra
    KINDHEIT UND ENTWICKLUNG, 2009, 18 (03): : 135 - 136
  • [37] Attention-deficit/hyperactivity disorder
    Faraone, Stephen V.
    Asherson, Philip
    Banaschewski, Tobias
    Biederman, Joseph
    Buitelaar, Jan K.
    Ramos-Quiroga, Josep Antoni
    Rohde, Luis Augusto
    Sonuga-Barke, Edmund J. S.
    Tannock, Rosemary
    Franke, Barbara
    NATURE REVIEWS DISEASE PRIMERS, 2015, 1
  • [38] Attention-deficit/hyperactivity disorder
    Torres Mohedas, J.
    Villares Alonso, R.
    NEUROLOGIA, 2008, : 9 - 14
  • [39] Attention-Deficit/Hyperactivity Disorder
    Banaschewski, Tobias
    Becker, Katja
    Doepfner, Manfred
    Holtmann, Martin
    Roesler, Michael
    Romanos, Marcel
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2017, 114 (09): : 149 - +
  • [40] Attention-deficit/hyperactivity disorder
    Faraone, Stephen V.
    Bellgrove, Mark A.
    Brikell, Isabell
    Cortese, Samuele
    Hartman, Catharina A.
    Hollis, Chris
    Newcorn, Jeffrey H.
    Philipsen, Alexandra
    Polanczyk, Guilherme V.
    Rubia, Katya
    Sibley, Margaret H.
    Buitelaar, Jan K.
    NATURE REVIEWS DISEASE PRIMERS, 2024, 10 (01)